Amarin Corp Plc (AMRN)

[Birdbrain Ideas]

Totally disagree with you about the share buyback, the announcement of which elevated us above a dollar long enough to get us off the NASDAQ listing death watch. It's pointless to sit on $320 million in cash when the company is operating at break-even. A lot of that money was originally earmarked to fund advertising and promotion costs in the U.S. before generics snuck in early and killed market growth. And none of us presumably know the details of what can be done with cash to try to convince doctors to prescribe Vascepa more often better than those who work at Amarin. If throwing cash at the problem was an easy solution, then big Pharma companies with lots of cash to blow would be able to get a lot of their slower selling drugs off the mat.

Buying back all those shares will boost the share price and make the company more attractive to buyers. And it tells Wall Street that the company is confident that profitability is around the corner and there is no reason anymore to hoard cash. To show my support for the plan, I picked up another 5,300 shares this morning.